<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://lipidbank.jp/mediawiki/index.php?action=history&amp;feed=atom&amp;title=LBF20406CV13</id>
	<title>LBF20406CV13 - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://lipidbank.jp/mediawiki/index.php?action=history&amp;feed=atom&amp;title=LBF20406CV13"/>
	<link rel="alternate" type="text/html" href="https://lipidbank.jp/mediawiki/index.php?title=LBF20406CV13&amp;action=history"/>
	<updated>2026-04-30T20:09:49Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.0</generator>
	<entry>
		<id>https://lipidbank.jp/mediawiki/index.php?title=LBF20406CV13&amp;diff=55205&amp;oldid=prev</id>
		<title>Editor at 06:02, 21 October 2010</title>
		<link rel="alternate" type="text/html" href="https://lipidbank.jp/mediawiki/index.php?title=LBF20406CV13&amp;diff=55205&amp;oldid=prev"/>
		<updated>2010-10-21T06:02:55Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 15:02, 21 October 2010&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l6&quot;&gt;Line 6:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 6:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|LipidBank=XPR8009&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|LipidBank=XPR8009&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|LipidMaps=LMFA03120009&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|LipidMaps=LMFA03120009&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|SysName=Methyl- (5-&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;trans,&lt;/del&gt;7&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-trans&lt;/del&gt;) -7- [ 4R-chloro-2-hydroxy-2- &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[&lt;/del&gt;cis-2-octenyl&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;] &lt;/del&gt;-5-oxo-3-cyclopentenylidene ] -5-heptenoic acid&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|SysName=Methyl- (&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;trans-&lt;/ins&gt;5&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;,trans&lt;/ins&gt;-7) -7- [ 4R-chloro-2-hydroxy-2- &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt; (&lt;/ins&gt;cis-2-octenyl&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;) &lt;/ins&gt;-5-oxo-3-cyclopentenylidene ] -5-heptenoic acid&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|Common Name=&amp;amp;&amp;amp;Chlorovulone II&amp;amp;&amp;amp;Methyl- (5E,7E) -7- [ 4R-chloro-2-hydroxy-2- [(&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Z)-2&lt;/del&gt;-octenyl&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;] &lt;/del&gt;-5-oxo-3-cyclopentenylidene ] -5-heptenoic acid&amp;amp;&amp;amp;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|Common Name=&amp;amp;&amp;amp;Chlorovulone II&amp;amp;&amp;amp;Methyl- (5E,7E) -7- [ 4R-chloro-2-hydroxy-2- [(&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;2Z&lt;/ins&gt;-octenyl&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;) &lt;/ins&gt;-5-oxo-3-cyclopentenylidene ] -5-heptenoic acid&amp;amp;&amp;amp;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|Optical=[ alpha ]_D  +22.7°(C 0.075, CHCl_3 )[[Reference:Iguchi_K:Kaneta_S:Mori_K:Yamada_Y:Honda_A:Mori_Y:,Tetrahedron Lett.,1985,26,5787|{{RelationTable/GetFirstAuthor|Reference:Iguchi_K:Kaneta_S:Mori_K:Yamada_Y:Honda_A:Mori_Y:,Tetrahedron Lett.,1985,26,5787}}]]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|Optical=[ alpha ]_D  +22.7°(C 0.075, CHCl_3 )[[Reference:Iguchi_K:Kaneta_S:Mori_K:Yamada_Y:Honda_A:Mori_Y:,Tetrahedron Lett.,1985,26,5787|{{RelationTable/GetFirstAuthor|Reference:Iguchi_K:Kaneta_S:Mori_K:Yamada_Y:Honda_A:Mori_Y:,Tetrahedron Lett.,1985,26,5787}}]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|Solubility=Chlorovulones are soluble in MeOH, EtOH, CHCl_3 , or hexane.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|Solubility=Chlorovulones are soluble in MeOH, EtOH, CHCl_3 , or hexane.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Editor</name></author>
	</entry>
	<entry>
		<id>https://lipidbank.jp/mediawiki/index.php?title=LBF20406CV13&amp;diff=55204&amp;oldid=prev</id>
		<title>Editor: New page: {{Lipid/Header}}  {{Hierarchy|{{PAGENAME}}}}  {{Metabolite |LipidBank=XPR8009 |LipidMaps=LMFA03120009 |SysName=Methyl- (5-trans,7-trans) -7- [ 4R-chloro-2-hydroxy-2- [cis-2-octenyl] -5-oxo...</title>
		<link rel="alternate" type="text/html" href="https://lipidbank.jp/mediawiki/index.php?title=LBF20406CV13&amp;diff=55204&amp;oldid=prev"/>
		<updated>2010-09-16T09:10:56Z</updated>

		<summary type="html">&lt;p&gt;New page: {{Lipid/Header}}  {{Hierarchy|{{PAGENAME}}}}  {{Metabolite |LipidBank=XPR8009 |LipidMaps=LMFA03120009 |SysName=Methyl- (5-trans,7-trans) -7- [ 4R-chloro-2-hydroxy-2- [cis-2-octenyl] -5-oxo...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Lipid/Header}}&lt;br /&gt;
&lt;br /&gt;
{{Hierarchy|{{PAGENAME}}}}&lt;br /&gt;
&lt;br /&gt;
{{Metabolite&lt;br /&gt;
|LipidBank=XPR8009&lt;br /&gt;
|LipidMaps=LMFA03120009&lt;br /&gt;
|SysName=Methyl- (5-trans,7-trans) -7- [ 4R-chloro-2-hydroxy-2- [cis-2-octenyl] -5-oxo-3-cyclopentenylidene ] -5-heptenoic acid&lt;br /&gt;
|Common Name=&amp;amp;&amp;amp;Chlorovulone II&amp;amp;&amp;amp;Methyl- (5E,7E) -7- [ 4R-chloro-2-hydroxy-2- [(Z)-2-octenyl] -5-oxo-3-cyclopentenylidene ] -5-heptenoic acid&amp;amp;&amp;amp;&lt;br /&gt;
|Optical=[ alpha ]_D  +22.7°(C 0.075, CHCl_3 )[[Reference:Iguchi_K:Kaneta_S:Mori_K:Yamada_Y:Honda_A:Mori_Y:,Tetrahedron Lett.,1985,26,5787|{{RelationTable/GetFirstAuthor|Reference:Iguchi_K:Kaneta_S:Mori_K:Yamada_Y:Honda_A:Mori_Y:,Tetrahedron Lett.,1985,26,5787}}]]&lt;br /&gt;
|Solubility=Chlorovulones are soluble in MeOH, EtOH, CHCl_3 , or hexane.&lt;br /&gt;
|UV Spectra= lambda _{max}(EtOH) 237 nm( epsilon 10000),312 nm( epsilon 10100)[[Reference:Iguchi_K:Kaneta_S:Mori_K:Yamada_Y:Honda_A:Mori_Y:,Tetrahedron Lett.,1985,26,5787|{{RelationTable/GetFirstAuthor|Reference:Iguchi_K:Kaneta_S:Mori_K:Yamada_Y:Honda_A:Mori_Y:,Tetrahedron Lett.,1985,26,5787}}]]&lt;br /&gt;
|IR Spectra= nu _{max}(CHCl_3 )3560,3300,1730,1705, and 1635cm^{-1}(Yamada Yasuji)&lt;br /&gt;
|NMR Spectra=^1 H-NMR(400MHz,CDCl_3 ) delta ppm0.88(3H,t,J=7.1Hz),1.30(6H,m),1.82(2H,quint.,J=7.4Hz),1.96(2H,brq,J=7.5Hz),2.30(2H,t,J=7.5Hz),2.35(2H,t,J=7.4Hz),2.68(1H,brdd,J=7.9,14.3Hz),2.81(1H,brdd,J=7.5,14.3Hz),3.67(3H,s),5.23(1H,ttd,J=1.4,7.7,10.9Hz),5.55(1H,brtd,J=7.5,10.9Hz),6.28(1H,td,J=7.4,15.1Hz),6.77(1H,tdd,J=1.3,11.9,15.1Hz),7.03(1H,d,J=11.9Hz),7.20(1H,s).[[Reference:Iguchi_K:Kaneta_S:Mori_K:Yamada_Y:Honda_A:Mori_Y:,Tetrahedron Lett.,1985,26,5787|{{RelationTable/GetFirstAuthor|Reference:Iguchi_K:Kaneta_S:Mori_K:Yamada_Y:Honda_A:Mori_Y:,Tetrahedron Lett.,1985,26,5787}}]]&lt;br /&gt;
|Source=Chlorovulones were isolated from Japanese soft coral, Stolonifer Clavularia viridis Quoy and Gaimard.[[Reference:Iguchi_K:Kaneta_S:Mori_K:Yamada_Y:Honda_A:Mori_Y:,Tetrahedron Lett.,1985,26,5787|{{RelationTable/GetFirstAuthor|Reference:Iguchi_K:Kaneta_S:Mori_K:Yamada_Y:Honda_A:Mori_Y:,Tetrahedron Lett.,1985,26,5787}}]][[Reference:Nagaoka_H:Iguchi_K:Miyakoshi_T:Yamada_N:Yamada_Y:,Tetrahedron Lett.,1986,27,223|{{RelationTable/GetFirstAuthor|Reference:Nagaoka_H:Iguchi_K:Miyakoshi_T:Yamada_N:Yamada_Y:,Tetrahedron Lett.,1986,27,223}}]]&lt;br /&gt;
|Chemical Synthesis=Photoisomerization of chlorovulone I (fluoresent lamp, benzene, 40 hr) gave a mixture of chlorovulones I, II and III.[[Reference:Iguchi_K:Kaneta_S:Mori_K:Yamada_Y:Honda_A:Mori_Y:,Tetrahedron Lett.,1985,26,5787|{{RelationTable/GetFirstAuthor|Reference:Iguchi_K:Kaneta_S:Mori_K:Yamada_Y:Honda_A:Mori_Y:,Tetrahedron Lett.,1985,26,5787}}]](-)-Cholovulone II was synthesized from D-(-)-diethyl tartarate.[[Reference:Nagaoka_H:Iguchi_K:Miyakoshi_T:Yamada_N:Yamada_Y:,Tetrahedron Lett.,1986,27,223|{{RelationTable/GetFirstAuthor|Reference:Nagaoka_H:Iguchi_K:Miyakoshi_T:Yamada_N:Yamada_Y:,Tetrahedron Lett.,1986,27,223}}]]&lt;br /&gt;
|Metabolism=&lt;br /&gt;
|Biological Activity=(-)-Chlorovulone II showed the strong antiproliferative and cytotoxic activities in himan promyelocytic leukemia (HL-60) ((IC_{50} 0.01  mu g/ml, cytotoxic effect &amp;gt;0.1  mu g/ml).[[Reference:Honda_A:Mori_Y:Iguchi_K:Yamada_Y:,Mol. Pharmacol.,1987,32,530|{{RelationTable/GetFirstAuthor|Reference:Honda_A:Mori_Y:Iguchi_K:Yamada_Y:,Mol. Pharmacol.,1987,32,530}}]]&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
{{Lipid/Footer}}&lt;/div&gt;</summary>
		<author><name>Editor</name></author>
	</entry>
</feed>